SlidesetViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016When to Treat HCV in a Waiting List Patient? - Stefano Fagiuoli, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016What Are the Treatment Options? - Xavier Forns, MDView Slideset
NTNorah TerraultMD, MPH, FAASLDSlidesetViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016Is Treatment Cost-effective? - Kosh Agarwal, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016Treatment Experienced GT3 patient with Cirrhosis - Geoffrey McCaughan, MD, PhDView Slideset
NTNorah TerraultMD, MPH, FAASLDSlidesetViral Hepatitis and Liver DiseaseOptimize Workshop: Using DAAs in Patients with Cirrhosis and Liver Recipients 2016Who Should We Treat? What is the “Point-of-No-Return”? - Norah Terrault, MD, MPH, FAASLDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2017Medicines Patent Pool’s approach to scale up access to HIV and HCV treatment- Esteban BurroneView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2017Micro-elimination as a strategy to reach global elimination- Jeffrey Lazarus, PhD, MIH, MAView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2017Prevention transmission strategies through strengthening the health system- Maia Butshashvili, MD, MS, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2017Prevention transmission strategies prior to infection - Incarceration- Lara Strick, MD, MSView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2017Prevention transmission strategies prior to infection - People who inject drugs- Diana Sylvestre, MDView Slideset
OLOlufunmilayo LesiMD, MBA, FWACP, FMCPSlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2017Real-life experiences - bottlenecks & hurdles- Nigeria, sub-Saharan Africa- Olufunmilayo Lesi, MD, MBA, FMCP, FWACPView Slideset
MHMargaret HellardAM, MBBS, FRACP, FAFPHM, PhDSlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2017Real-life experiences - bottlenecks & hurdles- Australia- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhDView Slideset
